CA2961195C - Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (piva) and applications of same - Google Patents
Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (piva) and applications of same Download PDFInfo
- Publication number
- CA2961195C CA2961195C CA2961195A CA2961195A CA2961195C CA 2961195 C CA2961195 C CA 2961195C CA 2961195 A CA2961195 A CA 2961195A CA 2961195 A CA2961195 A CA 2961195A CA 2961195 C CA2961195 C CA 2961195C
- Authority
- CA
- Canada
- Prior art keywords
- living subject
- peripheral
- peaks
- peripheral venous
- frequency spectrum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000002093 peripheral effect Effects 0.000 title claims abstract description 244
- 238000001990 intravenous administration Methods 0.000 title claims abstract description 98
- 206010021137 Hypovolaemia Diseases 0.000 title claims abstract description 48
- 206010020919 Hypervolaemia Diseases 0.000 title claims abstract description 42
- 238000004458 analytical method Methods 0.000 title claims abstract description 39
- 238000001514 detection method Methods 0.000 title abstract description 26
- 238000001228 spectrum Methods 0.000 claims abstract description 81
- 238000000034 method Methods 0.000 claims abstract description 67
- 210000003462 vein Anatomy 0.000 claims abstract description 27
- 238000010183 spectrum analysis Methods 0.000 claims abstract description 17
- 238000007619 statistical method Methods 0.000 claims abstract description 14
- 230000007423 decrease Effects 0.000 claims abstract description 11
- 238000012545 processing Methods 0.000 claims description 50
- 230000003595 spectral effect Effects 0.000 claims description 17
- 238000005070 sampling Methods 0.000 claims description 13
- 230000007246 mechanism Effects 0.000 claims description 11
- 238000012806 monitoring device Methods 0.000 claims description 10
- 230000036387 respiratory rate Effects 0.000 claims description 9
- 238000000502 dialysis Methods 0.000 claims description 8
- 238000001802 infusion Methods 0.000 claims description 6
- 238000000108 ultra-filtration Methods 0.000 claims description 5
- 210000001364 upper extremity Anatomy 0.000 claims description 5
- 208000004880 Polyuria Diseases 0.000 claims description 4
- 230000035619 diuresis Effects 0.000 claims description 4
- 230000006442 vascular tone Effects 0.000 claims description 4
- 230000002612 cardiopulmonary effect Effects 0.000 claims description 3
- 238000002618 extracorporeal membrane oxygenation Methods 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- 210000004369 blood Anatomy 0.000 abstract description 65
- 239000008280 blood Substances 0.000 abstract description 65
- 208000032843 Hemorrhage Diseases 0.000 abstract description 56
- 230000008859 change Effects 0.000 abstract description 8
- 239000012530 fluid Substances 0.000 description 29
- 238000012544 monitoring process Methods 0.000 description 21
- 230000000875 corresponding effect Effects 0.000 description 20
- 238000012360 testing method Methods 0.000 description 18
- 230000000004 hemodynamic effect Effects 0.000 description 16
- 206010016803 Fluid overload Diseases 0.000 description 13
- 241000282414 Homo sapiens Species 0.000 description 13
- 238000005399 mechanical ventilation Methods 0.000 description 13
- 230000035939 shock Effects 0.000 description 12
- 230000004872 arterial blood pressure Effects 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 238000005259 measurement Methods 0.000 description 11
- 238000009423 ventilation Methods 0.000 description 11
- 206010002091 Anaesthesia Diseases 0.000 description 10
- 241000282887 Suidae Species 0.000 description 10
- 230000037005 anaesthesia Effects 0.000 description 10
- 230000002008 hemorrhagic effect Effects 0.000 description 10
- 210000001147 pulmonary artery Anatomy 0.000 description 10
- 238000004422 calculation algorithm Methods 0.000 description 9
- 230000029058 respiratory gaseous exchange Effects 0.000 description 9
- 230000009466 transformation Effects 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 230000036772 blood pressure Effects 0.000 description 7
- 230000001276 controlling effect Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 230000006698 induction Effects 0.000 description 6
- 238000007675 cardiac surgery Methods 0.000 description 5
- 230000000642 iatrogenic effect Effects 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 230000002861 ventricular Effects 0.000 description 5
- 206010007559 Cardiac failure congestive Diseases 0.000 description 4
- 206010019280 Heart failures Diseases 0.000 description 4
- 208000032456 Hemorrhagic Shock Diseases 0.000 description 4
- 206010049771 Shock haemorrhagic Diseases 0.000 description 4
- 238000010171 animal model Methods 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000002637 fluid replacement therapy Methods 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 238000012546 transfer Methods 0.000 description 4
- 230000008733 trauma Effects 0.000 description 4
- 208000028399 Critical Illness Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 238000001356 surgical procedure Methods 0.000 description 3
- PIWKPBJCKXDKJR-UHFFFAOYSA-N Isoflurane Chemical compound FC(F)OC(Cl)C(F)(F)F PIWKPBJCKXDKJR-UHFFFAOYSA-N 0.000 description 2
- 241000219823 Medicago Species 0.000 description 2
- 241000751119 Mila <angiosperm> Species 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 206010040047 Sepsis Diseases 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000001447 compensatory effect Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000003205 diastolic effect Effects 0.000 description 2
- 238000012377 drug delivery Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000001105 femoral artery Anatomy 0.000 description 2
- 210000003191 femoral vein Anatomy 0.000 description 2
- 230000005484 gravity Effects 0.000 description 2
- 229960002725 isoflurane Drugs 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 238000007726 management method Methods 0.000 description 2
- 230000036581 peripheral resistance Effects 0.000 description 2
- 238000012552 review Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000002627 tracheal intubation Methods 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010067010 Anaphylactoid syndrome of pregnancy Diseases 0.000 description 1
- KMKBEESNZAPKMP-UHFFFAOYSA-N Biphenylindanone a Chemical compound CC=1C(C)=C2C(=O)C(C3CCCC3)CC2=CC=1OCC(C=1)=CC=CC=1C1=CC=C(C(O)=O)C=C1 KMKBEESNZAPKMP-UHFFFAOYSA-N 0.000 description 1
- 206010006322 Breath holding Diseases 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 208000004248 Familial Primary Pulmonary Hypertension Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010058558 Hypoperfusion Diseases 0.000 description 1
- 206010021138 Hypovolaemic shock Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
- 206010027727 Mitral valve incompetence Diseases 0.000 description 1
- 208000004221 Multiple Trauma Diseases 0.000 description 1
- 206010029315 Neuromuscular blockade Diseases 0.000 description 1
- 208000010378 Pulmonary Embolism Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000008166 Right Ventricular Dysfunction Diseases 0.000 description 1
- 206010039163 Right ventricular failure Diseases 0.000 description 1
- 206010040070 Septic Shock Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 238000013528 artificial neural network Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 238000009530 blood pressure measurement Methods 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000002695 general anesthesia Methods 0.000 description 1
- 208000011316 hemodynamic instability Diseases 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 229960003299 ketamine Drugs 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 229940127240 opiate Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000006461 physiological response Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229960004134 propofol Drugs 0.000 description 1
- OLBCVFGFOZPWHH-UHFFFAOYSA-N propofol Chemical compound CC(C)C1=CC=CC(C(C)C)=C1O OLBCVFGFOZPWHH-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 208000002815 pulmonary hypertension Diseases 0.000 description 1
- 238000002106 pulse oximetry Methods 0.000 description 1
- 230000035485 pulse pressure Effects 0.000 description 1
- 210000002321 radial artery Anatomy 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000036391 respiratory frequency Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000004043 responsiveness Effects 0.000 description 1
- 210000005245 right atrium Anatomy 0.000 description 1
- 230000006814 right ventricular dysfunction Effects 0.000 description 1
- 230000036303 septic shock Effects 0.000 description 1
- 206010040560 shock Diseases 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229940052907 telazol Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- BPICBUSOMSTKRF-UHFFFAOYSA-N xylazine Chemical compound CC1=CC=CC(C)=C1NC1=NCCCS1 BPICBUSOMSTKRF-UHFFFAOYSA-N 0.000 description 1
- 229960001600 xylazine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/021—Measuring pressure in heart or blood vessels
- A61B5/0215—Measuring pressure in heart or blood vessels by means inserted into the body
- A61B5/02152—Measuring pressure in heart or blood vessels by means inserted into the body specially adapted for venous pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
- A61B5/02042—Determining blood loss or bleeding, e.g. during a surgical procedure
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Surgery (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Physiology (AREA)
- Vascular Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- External Artificial Organs (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Signal Processing (AREA)
- Mathematical Physics (AREA)
- Computer Networks & Wireless Communication (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462049829P | 2014-09-12 | 2014-09-12 | |
| US62/049,829 | 2014-09-12 | ||
| US14/853,504 | 2015-09-14 | ||
| PCT/US2015/050001 WO2016040947A1 (en) | 2014-09-12 | 2015-09-14 | Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (piva) and applications of same |
| US14/853,504 US20160073959A1 (en) | 2014-09-12 | 2015-09-14 | Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (piva) and applications of same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2961195A1 CA2961195A1 (en) | 2016-03-17 |
| CA2961195C true CA2961195C (en) | 2023-01-17 |
Family
ID=55453596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2961195A Active CA2961195C (en) | 2014-09-12 | 2015-09-14 | Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (piva) and applications of same |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20160073959A1 (enExample) |
| EP (1) | EP3190960B1 (enExample) |
| JP (2) | JP2017530766A (enExample) |
| CN (1) | CN106999061B (enExample) |
| BR (1) | BR112017005003A2 (enExample) |
| CA (1) | CA2961195C (enExample) |
| CO (1) | CO2017003535A2 (enExample) |
| MX (1) | MX386737B (enExample) |
| SG (1) | SG11201701987VA (enExample) |
| WO (1) | WO2016040947A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10542961B2 (en) | 2015-06-15 | 2020-01-28 | The Research Foundation For The State University Of New York | System and method for infrasonic cardiac monitoring |
| CN110248596B (zh) * | 2016-12-15 | 2022-12-20 | 巴克斯特国际公司 | 用于从感测的静脉波形监视和确定患者参数的系统和方法 |
| US10813597B2 (en) * | 2017-04-14 | 2020-10-27 | The Regents Of The University Of California | Non-invasive hemodynamic assessment via interrogation of biological tissue using a coherent light source |
| BR112019027925A2 (pt) * | 2017-06-30 | 2020-07-14 | Baxter International Inc. | sistemas a métodos para filtrar ruídos e analisar sinais de forma de onda venosa |
| WO2019118822A1 (en) | 2017-12-15 | 2019-06-20 | Baxter International Inc. | Systems and methods for filtering medical device noise artifacts from venous waveform signals |
| US11039754B2 (en) * | 2018-05-14 | 2021-06-22 | Baxter International Inc. | System and method for monitoring and determining patient parameters from sensed venous waveform |
| US20230165520A1 (en) * | 2020-04-17 | 2023-06-01 | Bioventures, Llc | Methods and systems for predicting the effect of inhaled and infused anesthetics |
| EP4171357A1 (en) | 2020-06-24 | 2023-05-03 | Baxter International Inc. | Patient-monitoring system |
| BR112022026198A2 (pt) | 2020-08-12 | 2023-03-07 | Baxter Int | Curativo iv com sensores embutidos para medir infiltração de fluido e parâmetros fisiológicos |
| JP7664758B2 (ja) * | 2021-05-19 | 2025-04-18 | 日本光電工業株式会社 | 循環血液量判定装置、循環血液量判定プログラム、および循環血液量判定方法 |
| US12310703B2 (en) | 2023-06-01 | 2025-05-27 | Endophys Holdings, Llc | Vascular assessment using statistical analysis of rapid blood pressure readings |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5351686A (en) * | 1990-10-06 | 1994-10-04 | In-Line Diagnostics Corporation | Disposable extracorporeal conduit for blood constituent monitoring |
| US6002952A (en) * | 1997-04-14 | 1999-12-14 | Masimo Corporation | Signal processing apparatus and method |
| US6471656B1 (en) * | 1999-06-25 | 2002-10-29 | Florence Medical Ltd | Method and system for pressure based measurements of CFR and additional clinical hemodynamic parameters |
| US6623470B2 (en) * | 2001-06-27 | 2003-09-23 | Cleveland Clinic Foundation | Method and apparatus for controlling blood volume and hydration and for indicating resuscitation status of a patient using peripheral venous pressure as a hemodynamic parameter |
| WO2004080300A1 (en) * | 2003-03-12 | 2004-09-23 | Yale University | Method of assesing blood volume using photoelectric plethysmography |
| US7798973B2 (en) * | 2005-10-13 | 2010-09-21 | Cardiac Pacemakers, Inc. | Detection of hypovolemia using implantable medical device |
| AU2008237177A1 (en) * | 2007-04-05 | 2008-10-16 | Velomedix, Inc | Automated therapy system and method |
| US8727997B2 (en) * | 2008-10-17 | 2014-05-20 | Yale University | Volume status monitor: peripheral venous pressure, hypervolemia and coherence analysis |
| US9119551B2 (en) * | 2010-11-08 | 2015-09-01 | Vasonova, Inc. | Endovascular navigation system and method |
| WO2013012721A2 (en) * | 2011-07-15 | 2013-01-24 | Vanderbilt University | Apparatus and methods for measuring peripheral venous pressure and applications of same |
| US9332913B2 (en) * | 2011-12-21 | 2016-05-10 | Pacesetter, Inc. | System and method for discriminating hypervolemia, hypervolemia and euvolemia using an implantable medical device |
| CA2884397C (en) * | 2012-09-10 | 2019-10-08 | Vanderbilt University | Intravenous access device having integrated hemodynamic resuscitation system and related methods |
-
2015
- 2015-09-14 EP EP15840046.5A patent/EP3190960B1/en active Active
- 2015-09-14 WO PCT/US2015/050001 patent/WO2016040947A1/en not_active Ceased
- 2015-09-14 BR BR112017005003A patent/BR112017005003A2/pt active Search and Examination
- 2015-09-14 CA CA2961195A patent/CA2961195C/en active Active
- 2015-09-14 SG SG11201701987VA patent/SG11201701987VA/en unknown
- 2015-09-14 MX MX2017003272A patent/MX386737B/es unknown
- 2015-09-14 CN CN201580049227.8A patent/CN106999061B/zh active Active
- 2015-09-14 JP JP2017513668A patent/JP2017530766A/ja active Pending
- 2015-09-14 US US14/853,504 patent/US20160073959A1/en not_active Abandoned
-
2017
- 2017-04-12 CO CONC2017/0003535A patent/CO2017003535A2/es unknown
-
2020
- 2020-06-03 JP JP2020096542A patent/JP6780147B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020157080A (ja) | 2020-10-01 |
| CA2961195A1 (en) | 2016-03-17 |
| CN106999061B (zh) | 2020-08-07 |
| SG11201701987VA (en) | 2017-04-27 |
| EP3190960B1 (en) | 2022-01-12 |
| EP3190960A4 (en) | 2018-05-02 |
| MX386737B (es) | 2025-03-19 |
| JP6780147B2 (ja) | 2020-11-04 |
| BR112017005003A2 (pt) | 2018-06-05 |
| MX2017003272A (es) | 2017-07-07 |
| US20160073959A1 (en) | 2016-03-17 |
| CO2017003535A2 (es) | 2017-07-19 |
| JP2017530766A (ja) | 2017-10-19 |
| EP3190960A1 (en) | 2017-07-19 |
| WO2016040947A1 (en) | 2016-03-17 |
| CN106999061A (zh) | 2017-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2961195C (en) | Hypovolemia/hypervolemia detection using peripheral intravenous waveform analysis (piva) and applications of same | |
| US20210267468A1 (en) | Hypovolemia/hypervolemia and intravenous infiltration detection using peripheral intravenous waveform analysis (piva) and applications of same | |
| Pereira de Souza Neto et al. | Predicting fluid responsiveness in mechanically ventilated children under general anaesthesia using dynamic parameters and transthoracic echocardiography | |
| KR102444875B1 (ko) | 출혈 검출 및 가이드형 소생법을 위한 디바이스 및 방법, 및 이의 애플리케이션들 | |
| US10456046B2 (en) | Device and method for hemorrhage detection and guided resuscitation and applications of same | |
| Chen et al. | Continuous and noninvasive measurement of systolic and diastolic blood pressure by one mathematical model with the same model parameters and two separate pulse wave velocities | |
| US10085653B2 (en) | Pulse transmit time measurement device and method | |
| de Wilde et al. | Non‐invasive continuous arterial pressure and pulse pressure variation measured with Nexfin® in patients following major upper abdominal surgery: a comparative study | |
| Hocking et al. | Peripheral iv analysis (PIVA) of venous waveforms for volume assessment in patients undergoing haemodialysis | |
| Truijen et al. | The effect of haemodynamic and peripheral vascular variability on cardiac output monitoring: Thermodilution and non‐invasive pulse contour cardiac output during cardiothoracic surgery | |
| Hoftman et al. | Peripheral venous pressure as a predictor of central venous pressure during orthotopic liver transplantation | |
| Alvis et al. | Non-Invasive Venous waveform Analysis (NIVA) for monitoring blood loss in human blood donors and validation in a porcine hemorrhage model | |
| Lansdorp et al. | Non-invasive measurement of pulse pressure variation and systolic pressure variation using a finger cuff corresponds with intra-arterial measurement | |
| Polanco et al. | Practical issues of hemodynamic monitoring at the bedside | |
| Pielmus et al. | Surrogate based continuous noninvasive blood pressure measurement | |
| Kenny et al. | The Doppler shock index measured by a wearable ultrasound patch accurately detects moderate‐to‐severe central hypovolemia during lower body negative pressure | |
| Tomita et al. | Non-invasive monitoring using photoplethysmography technology | |
| US20220015646A1 (en) | Fluid responsiveness detection device and method | |
| Saugel et al. | Journal of Clinical Monitoring and Computing 2017 end of year summary: cardiovascular and hemodynamic monitoring | |
| Yıldızdaş et al. | Point-of-care ultrasound assessment of the inferior vena cava distensibility index in mechanically ventilated children in the operating room. | |
| Garg et al. | POCUS and Fluid Responsiveness on Venoarterial ECMO | |
| Engelbert | The prediction of early sepsis with wearable devices | |
| Yildizdaş et al. | Point-of-care ultrasound assessment of the inferior vena cava distensibility index inmechanically ventilated children in the operating room | |
| Myatra et al. | Tidal Volume Challenge Test: Expanding Possibilities | |
| Squara et al. | Bioreactance® |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20180913 |
|
| EEER | Examination request |
Effective date: 20180913 |
|
| EEER | Examination request |
Effective date: 20180913 |
|
| EEER | Examination request |
Effective date: 20180913 |